Amy Lanouette Email & Phone Number

Amy Lanouette is a Genetic Services Account Manager - Southwest at Vitrolife & Igenomix USA, Part of Vitrolife Group. They possess expertise in medical devices, biotechnology, infectious diseases, oncology, capital equipment and 45 more skills. Colleagues describe them as "I thoroughly enjoyed my time working with Amy at CanCare. Her role as Director of Community Partnerships and mine as Director of Communications presented us many opportunities to partner together on projects for both mission awareness and donation support in the community. Amy is professional, dedicated, and was always committed to getting results for the organization and the people we served. Not only is she a strong fundraiser and tactical presenter, exceeding her goals with corporate giving and sponsorships for every CanCare event we worked on together, she also pays close attention to detail which is essential in her line of work. Community partners appreciated her ability to be informative and clear, while delivering services tailored individually to each company. Being able to balance many different presentation styles and knowing how to adjust to her audience comes naturally to Amy. Whether addressing a group of clergy members, a group of oncologists, C-suite executives, or a charity-based women’s group, Amy knows how to connect with people professionally, while adding a personal touch that lets them know she is engaged in what she is representing. During our years at CanCare, I came to know Amy as a team player, keenly focused on the tasks at hand while also helping others reach their goals. She sets her standards high and is a truly valuable asset to any team." and "I would highly recommend Amy for molecular diagnostic sales. Amy has high energy level. She is very knowledgeable and can come up to speed in a short amount of time. Amy also does a great job identifying who the decision makers are. She has great rapport and follow up with her customers. She would be an asset to anyone's team."

Listed skills include Medical Devices, Biotechnology, Infectious Diseases, Oncology, and 46 others.